In order to prepare, at low cost, new compounds active against Plasmodium falciparum, and with a less side-effects, we have designed and synthesized a library of 1,4-disubstituted piperidine derivatives from 4-aminopiperidine derivatives 6. The resulting compound library has been evaluated against chloroquine-sensitive (3D7) and chloroquine-resistant (W2) strains of P. falciparum. The most active molecules-compounds 12d (13.64 nM (3D7)), 13b (4.19 nM (3D7) and 13.30 nM (W2)), and 12a (11.6 nM (W2))-were comparable to chloroquine (22.38 nM (3D7) and 134.12 nM (W2)).
Introduction
This year's World Health Organization (WHO) report shows that after an unprecedented period of success in global malaria control, progress has stalled [1] . In 2016, there were an estimated 216 million cases of malaria, an increase of about 5 million cases over 2015. Deaths reached 445,000, a similar number to the previous year.
Malaria-related mortality followed the same trend, i.e., a decline from 2010 to 2014, and then an increase in 2015 and 2016. According to this report, it is in the WHO African region that the increase in cases of malaria and associated deaths was the most significant. The African region still accounts for some 90% of worldwide malaria cases and related deaths. Fifteen countries, all but one in sub-Saharan Africa, account for 80% of the global burden of malaria.
One of the biggest challenges facing malaria chemotherapy is the rapid emergence of resistance to existing antimalarial drugs [2] . Chloroquine was replaced as first line therapy by the sulfonamide antimalarials and, later on, artemisinin combination therapy (ACT), following the development of widespread resistance against the drug by Plasmodium falciparum [3] . This challenge underscores the need for the continued search for new antimalarials.
The 4-arylaminopiperidine is a structural moiety found in many alkaloids [4] [5] [6] [7] [8] [9] [10] [11] and pharmaceutical products such as fentanyl and structurally-related analgesic opioids or H1-antihistamines agents such as bamipine [12] [13] [14] [15] [16] [17] and neurokinin 1 (NK1) receptor antagonists [18] [19] [20] . Studies have shown that compounds with piperidine rings [4, 8, [21] [22] [23] [24] [25] [26] have good selectivity and activity for the P. falciparum strain.
Research is being pursued for the discovery of new antimalarials with less side effects, a faster onset of action and a better rate of response [4, 8, [21] [22] [23] [24] [25] [26] . In the process of searching for new small molecules interacting with the P. falciparum strain, we have identified the target compounds A with various R1, R2 and R3 substituents ( Figure 1 ). In this paper, we describe the synthesis of some new derivatives with potential antimalarial properties. 
Results and Discussion

Chemistry
The key compound 6 has been synthesized through a three-step process according to the Scheme 1 [29] . Thus, reductive amination [30] [31] [32] [33] of N-boc-piperidin-4-one (1) with anilines 2a, b in CH2Cl2, gave compounds 3a, b in 75-85% yield. Acylation of the sodium salts of 3 with phenoxyacetyl chlorides 4 in CH2Cl2 at 0 °C furnished compounds 5 (85-90%). Final deprotection [34, 35] of 5 using trifluoroacetic acid at room temperature provided compounds 6a-b (50-95%) (Scheme 1).
Scheme 1. Synthesis of compounds 6a-b.
The alkylation of 3 with the acetyl chloride supplied compounds 7 in 85% yield. The condensation of 7 with the phenol 8 gave compounds 9 (78-80%). Final deprotection [34, 35 ] of 9 using 
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Scheme 3. Synthesis of compounds 5a and 10.
A pharmaco-modulation has been achieved on the parent molecule 6 taking advantage of the nucleophilicity of the piperidine nitrogen leading to compounds 17-34 in good yield. Thus, reductive amination [30] [31] [32] [33] of 6 with benzaldehyde derivatives in 1,2-dichloroethane (ClCH2CH2Cl), gave compounds A (Scheme 4) ( Table 2) . Condensation of phenoxyacetyl chloride with compound 3a in the presence of triethylamine at room temperature in acetone gave compounds 5a (55%) and 10 (30%) (Scheme 3). In this reaction we used excess phenoxyacetyl chloride, and we think that this excess probably made the reaction medium acidic which cause the cleavage of the N-Boc protective group. To avoid this side reaction, we used NaH in CH 2 Cl 2 which furnished compound 5a (Scheme 1).
A pharmaco-modulation has been achieved on the parent molecule 6 taking advantage of the nucleophilicity of the piperidine nitrogen leading to compounds 17-34 in good yield. Thus, reductive amination [30-33] of 6 with benzaldehyde derivatives in 1,2-dichloroethane (ClCH2CH2Cl), gave compounds A (Scheme 4) ( Table 2) . A pharmaco-modulation has been achieved on the parent molecule 6 taking advantage of the nucleophilicity of the piperidine nitrogen leading to compounds 17-34 in good yield. Thus, reductive amination [28] [29] [30] [31] of 6 with benzaldehyde derivatives in 1,2-dichloroethane (ClCH 2 CH 2 Cl), gave compounds A (Scheme 4) ( Table 2) . 
The Antimalarial Activity of Derivatives 6 and Target Compounds A
Studies have shown that compounds with piperidine rings [21] [22] [23] [24] [25] [26] [27] [28] have good selectivity and activity for the P. falciparum strain. This prompted us to assess their antiplasmodial activity against the chloroquine-sensitive 3D7 and chloroquine-resistant W2 strains of P. falciparum as well as their cytotoxic activity against HUVEC cells (Tables 3 and 4 ). Solutions of the 22 synthetic products and the negative control (chloroquine (CQ)) were prepared by two-fold dilution, in a dose-titration range of 0.098-100 µg/mL, to obtain 11 concentrations each, and all of them were inactive against W2 (IC50 > 100). The compounds exhibited activities in the nanomolar range against both parasitic strains. Their cytotoxicity against HUVEC ranged from CC50 0.052 ± 0.004 to >100 mM, thus resulting in varied selectivity indexes (SI), 26 for 13b in the 3D7 strain and >11.3 for 14c in the W2 strain. Compared with chloroquine (IC50 = 22.38 (3D7) and 134.12 (W2)), the compounds 13b (IC50 = 13.30 nM) and 12a (IC50 = 11.06 nM) showed a strong activity against W2. Molecules 13b (IC50 = 4.19 nM), 12d (IC50 = 13.64 nM), 14d (IC50 = 14.85 nM) and 6b (IC50 = 17, 42 nM) had the highest activity against 3D7.
Interestingly, compounds 6c and 6d are inactive against both strains. However, after pharmacomodulation on the nitrogen atom, their derivatives 12d, 14d, 17c, 13c and 14c showed good activity against both strains.
Compound 13b exhibits 5-fold more activity against strain 3D7 and 10-fold more against strain W2 with very low cytotoxicity (CC50 = 112 nM), resulting in a high selectivity index (SI = 26.7 (3D7) and 8.4 (W2), respectively) relative to chloroquine (CC50 = 37.56 nM, SI = 1.7 (3D7) and 0.3 (W2)). 
Studies have shown that compounds with piperidine rings [4, 8, [21] [22] [23] [24] [25] [26] have good selectivity and activity for the P. falciparum strain. This prompted us to assess their antiplasmodial activity against the chloroquine-sensitive 3D7 and chloroquine-resistant W2 strains of P. falciparum as well as their cytotoxic activity against HUVEC cells (Tables 3 and 4 ). Solutions of the 22 synthetic products and the negative control (chloroquine (CQ)) were prepared by two-fold dilution, in a dose-titration range of 0.098-100 µg/mL, to obtain 11 concentrations each, and all of them were inactive against W2 (IC 50 > 100). The compounds exhibited activities in the nanomolar range against both parasitic strains. Their cytotoxicity against HUVEC ranged from CC 50 0.052 ± 0.004 to >100 mM, thus resulting in varied selectivity indexes (SI), 26 for 13b in the 3D7 strain and >11.3 for 14c in the W2 strain. Compared with chloroquine (IC 50 = 22.38 (3D7) and 134.12 (W2)), the compounds 13b (IC 50 = 13.30 nM) and 12a (IC 50 = 11.06 nM) showed a strong activity against W2. Molecules 13b (IC 50 = 4.19 nM), 12d (IC 50 = 13.64 nM), 14d (IC 50 = 14.85 nM) and 6b (IC 50 = 17, 42 nM) had the highest activity against 3D7.
Compound 13b exhibits 5-fold more activity against strain 3D7 and 10-fold more against strain W2 with very low cytotoxicity (CC 50 = 112 nM), resulting in a high selectivity index (SI = 26.7 (3D7) and 8.4 (W2), respectively) relative to chloroquine (CC 50 = 37.56 nM, SI = 1.7 (3D7) and 0.3 (W2)).
Substitution of the piperidine nitrogen atom with a pentafluorobenzyl moiety did not significantly alter the activity of its derivative molecules against both strains. Indeed, the compounds 17b and 17d, derived from 6b and 6d, respectively, remained inactive while the activity of 17a (37.63 nM (3D7) and 47.84 nM (W2)) and 17c (14. 65 nM (3D7) and 36.88 nM (W2)) respectively, and 6a (34.46 nM (3D7) and 61.37 nM (W2)) and 6c (17.42 nM (3D7) and 30.35 nM (W2)) varied slightly. 
Materials and Methods
Apparatus, Materials, and Analytical Reagents
All chemical reagents and anhydrous solvents were obtained from commercial sources and used without further purification. The 1 H-and 13 C-NMR spectra were recorded in CDCl 3 at ambient temperature on an AMX 500 spectrometer (Bruker, Palaiseau, France). Some product structures were confirmed by DEPT 135, HMQC and HMBC experiments. Chemical shifts are given in δ (ppm) and coupling constants J (Hz) relative to TMS used as internal standard; multiplicities were recorded as s (singlet), d (doublet), dd (double doublet), t (triplet), dt (double triple), q (quartet) or m (multiplet). Reactions involving anhydrous conditions were conducted in dry glassware under a nitrogen atmosphere. The infrared spectra have been recorded on a model 842 spectrometer (Perkin-Elmer, 842) using polystyrene as reference. The melting points have been measured on a Tottoli S Bucchi device (Buchi, Rungis, France). Microanalysis have been done on a Perkin-Elmer 2400-CMN apparatus (Perkin ElmerVillebon-sur-Yvette, France). GC/MS conditions: Analyses were performed using a 5890 gas chromatogram connected to a G 1019 A mass spectrometer (both from Hewlett Packard, Alpharetta, GA, USA) operating in the electrospray ionization mode (ESI).
Chemistry
General procedure for the Synthesis of tert-Butyl 4-(phenylamino) Piperidine-1-carboxylates 3a-b
A solution of aniline (1 equiv) in 1,2-dichloroethane (100 mL) containing t-butyl-4-oxo-1-piperidine carboxylate (1 equiv), sodium triacetoxyborohydride (1.5 equiv) and acetic acid (1.5 equiv) was stirred for 24 h at 20 • C. 1N NaOH (50 mL, 50 mmol) and 50 mL of ethyl acetate were added. The phases were separated and the aqueous layer was extracted with ethyl acetate (3x25 mL). The combined organic layers were dried over MgSO 4, filtered and concentrated under reduced pressure. The residue was purified by crystallization (ether petroleum/ethyl acetate (8:2)). 
General Procedure for the Coupling with Phenoxyacetyl chloride: Synthesis of Compounds 5a-b
To an ice-cooled suspension of sodium hydride (60% in mineral oil, 2 equiv) in CH 2 Cl 2 (10 mL) was added dropwise a solution of compound 3 (1 equiv), in CH 2 Cl 2 (15 mL). After stirring 15 min phenoxyacetyl chloride 4 (2 equiv) was added. The reaction mixture was stirred for 1 h at 0 • C, and the temperature was raised to room temperature during 3 h. 20 mL of saturated solution of NaHCO 3 was carefully added. The aqueous layer was extracted with CH 2 Cl 2 (3 × 20 mL). The combined organic phases were dried over MgSO 4 , and concentrated in vacuum. The crude product was purified by crystallisation (ether petroleum/ethyl acetate (8:2)).
tert-Butyl 4-(2-phenoxy-N-phenylacetamido) piperidine-1-carboxylate (5a). Following the general procedure, sodium hydride (60% in mineral oil, 0.723 g, 18.1 mmol) in CH 2 Cl 2 (10 mL) was added dropwise a solution of compound 3a (2.5 g, 9.05 mmol), in CH 2 Cl 2 (15 mL). After stirring 15 min phenoxyacetyl chloride (2.5 mL, 18.1 mmol) was added to give compound 5a (3.06 g, 82%). 1 H-NMR (CDCl 3 ): 1.25 (m, 2H, CH 2 ); 1.4 (s, 9H); 1.8 (m, 2H, CH 2 ); 2.9 (m, 2H, CH 2 ); 4.1 (m, 2H, CH 2 ); 4.25 (m, 2H, CH 2 ); 4.8 (m, 1H, CH); 6.7-7.5 (m, 10H aromatic). 13 tert-Butyl 4-(N-(3-fluorophenyl)-2-phenoxyacetamido) piperidine-1-carboxylate (5b). Following the general procedure, sodium hydride (60% in mineral oil, 0.677 g, 16.93 mmol) in CH 2 Cl 2 (10 mL) was added dropwise a solution of compound 3b (2.49 g, 8.46 mmol), in CH 2 Cl 2 (15 mL). After stirring 15 min phenoxyacetyl chloride (2.88 g, 16.93 mmol) was added to give compound 5b (2.34 g, 65%). 1 
General Procedure for the Coupling with Chloroacetyl chloride: Synthesis of Compounds 7a-b
One equiv of compound 3 was dissolved in 25 mL of CH 2 Cl 2 , 2 equiv. of potassium carbonate were added and the mixture was cooled to 0 • C. Two equiv. of chloroacetyl chloride were added to 0 • C, and the mixture was stirred overnight. The reaction was quenched by addition of a saturated solution of NaHCO 3 (25 mL), the aqueous phase was decanted and extracted twice with 15 mL of CH 2 Cl 2 . Combined organic phases were washed with water and brine, dried over MgSO 4 and concentrated in vacuum. The crude product was purified by crystallisation (ether petroleum/ethyl acetate (8:2)).
tert-Butyl-4-(2-chloro-N-phenylacetamido) piperidine-1-carboxylate (7a). Following the general procedure, 2.5 g (9.03 mmol) of compound 3a were dissolved in 25 mL of CH 2 Cl 2 , 2.5 g (18.06 mmol) of potassium carbonate were added and the mixture was cooled to 0 • C. 2.04 g (18.06 mmol) of chloroacetyl chloride were added, and the mixture was stirred overnight to afford 7a as a white solid (2.55 g, 80%), m.p.: tert-Butyl 4-(2-chloro-N-(3-fluorophenyl) acetamido)piperidine-1-carboxylate (7b). Following the general procedure, 2.5 g (8.46 mmol) of compound 3b were dissolved in 25 mL of CH 2 Cl 2 , then 2.34 g (16.93 mmol) of potassium carbonate were added and the mixture was cooled to 0 • C. Chloroacetyl chloride (1.91 g, 18.06 mmol) was added, and the mixture was stirred overnight to afford 7b (2.66 g, 85%), m.p.: 90 • C. 1 
General Procedure for Deprotection: Synthesis of 6a-b
One equiv of compound 5 was dissolved in 15 mL of CH 2 Cl 2 , and 13 equiv of trifluoroacetic acid were added. After 2 h of stirring at room temperature, the reaction mixture was concentrated under vacuum. The residue was dissolved in 5 mL of ethyl acetate then neutralized with NaHCO 3 (5%). The aqueous layer was extracted with ethyl acetate (4x5mL). The combined organic phases were dried over MgSO 4 , filtered and concentrated under reduced pressure. The crude product was purified by crystallisation (ether petroleum/ethyl acetate (8:2)).
2-Phenoxy-N-Phenyl-N-(piperidin-4-yl) acetamide (6a). Following the general procedure, 3.06 g (7.48 mmol) of compound 5a were dissolved in 15 mL of CH 2 Cl 2 , then 7.49 mL (97.24 mmol) of trifluoroacetic acid were added to produce compound 6a (1.15 g, 50%); m.p.: 59 • C. 1 H-NMR (CDCl 3 , 600 MHz): 1.5 (m, 2H, CH 2 ); 1.9 (m, 2H, CH 2 ); 2.7 (m, 2H, CH 2 ); 3.4 (m, 2H, CH 2 ); 3.4 (broad, 1H, NH); 4.6 (s, 2H, O-CH 2 ); 4.75 (m, 1H, CH), 6.5-7.7 (m, 10H aromatic). 13 2-(2-Chlorophenoxy)-N-Phenyl-N-(piperidin-4-yl) acetamide (6c). Compound 9 (3.90 g, 8.78 mmol) was dissolved in 15 mL of CH 2 Cl 2 , then 8.73 mL (114.14 mmol) of trifluoroacetic acid were added, to give 6c (3.02 g, 95%); m.p.: 161 • C; 1 H-NMR (CDCl 3 , 600 MHz): 1.70 (m, 2H, CH 2 ); 1.93 (broad, 1H, NH); 2.06 (m, 2H, CH 2 ); 2.97 (m, 2H, CH 2 ); 3.38 (m, 2H, CH 2 ); 4.37 (s, 2H, CH 2 ); 4.77 (m, 1H, CH); 6.5-7.5 (m, 9H Ar). 13 
General Procedure for Synthesis of Target Compounds A
A solution of benzaldehyde derivatives (1 equiv) in 1,2-dichloroethane containing compound 6 (1 equiv), sodium triacetoxyborohydride (1.5 equiv) and acetic acid (1.5 equiv) was stirred for 24 h at 20 • C. 1N NaOH (15 mL) and 15 mL of ethyl acetate were added. The phases were separated and the aqueous layer was extracted with ethyl acetate (3 × 15 mL). The combined organic layers were dried over MgSO 4, filtered and concentrated under reduced pressure. The residue was purified by chromatography on silica gel (petroleum ether/EtOAc (8:2)). N-(1-(2-Bromobenzyl)piperidin-yl)-2-(2-chlorophenoxy)-N-(3-fluorophenyl) acetamide (13d). Following the general procedure, benzaldehyde derivative 11 (R 3 = Br (o)) (76.63 mg, 0.4142 mmol); compound 6d (150 mg, 0.4142 mmol); sodium triacetoxyborohydride (131.6 mg, 0.6213 mmol) and acetic acid (37.3 mg, 0.6213 mmol) in 1,2-dichloroethane (5 mL) was stirred for 24 h at 20 • C to furnish 13d (0.1295 g, 59%); m.p.: 100 • C; 1 H-NMR (CDCl 3 , 600 MHz): 1.33 (m, 2H, CH 2 ); 1.80 (m, 2H, CH 2 ); 2.23 (m, 2H, CH 2 ); 2.92 (m, 2H, CH 2 ); 3.54 (s, 2H, CH 2, ); 4.37 (s, 2H, CH 2 ); 4.74 (m, H, CH); 6.73-7.47 (m, 12H aromatic). 13 N-(1-(2-Chlorobenzyl)piperidin-4-yl)-2-phenoxy-N-phenylacetamide (14a). Following the general procedure for reductive amination using benzaldehyde derivative 11 (R 3 = Cl (o)) (43.5 mg, 0.4838 mmol); compound 6a (150 mg, 0.4838 mmol); sodium triacetoxyborohydride (153.8 mg, 0.7253 mmol) and acetic acid (43.5 mg, 0.7253 mmol) in 1,2-dichloroethane (5 mL) gave title compound 14a (0.109 g, 52%); m.p.: 69 • C. 1 H-NMR (CDCl 3 , 500 MHz): 1.47 (m, 2H, CH 2 ); 1.81 (m, 2H, CH 2 ); 2.28 (m, 2H, CH 2 ); 2.94 (m, 2H, CH 2 ); 3.59 (s, 2H, CH 2 ); 4.23 (s, 2H, CH 2 ); 4.67 (m, H, CH); 6.73-7.47 (m, 14H aromatic). 13 C-NMR (125 MHz, CDCl 3 ) δ: 30.32 (2× CH 2 ); 42.30 (2× CH 2 ); 53.03 (CH 2 ); 66.82 (CH 2 ); 114.84
Conclusions
In this study, we have prepared a small library of new nitrogen heterocycles displaying piperidine scaffolds using a flexible synthetic approach. Eighteen new derivatives were prepared in good yield. The antimalarial activity of these compounds has been described. The compounds were tested against P. falciparum 3D7 strains and W2. The best result is observed with the compounds 13b against the 3D7 strain and 12a against the W2 one with a selectivity index greater than chloroquine. We observed that modification with different R groups, for example compound 12a (R 1 = R 2 = R 3 = H) in 13b (R 1 = F, R 2 = H, R 3 = Br) significantly modulated the activity of the tested molecules. These molecules could be further optimized to provide good malaria drug candidates.
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